Advertisement

Journal of Biomolecular NMR

, Volume 22, Issue 3, pp 211–223 | Cite as

Solution structure and dynamics of melanoma inhibitory activity protein

  • Julie C. Lougheed
  • Peter J. Domaille
  • Tracy M. Handel
Article

Abstract

Melanoma inhibitory activity (MIA) is a small secreted protein that is implicated in cartilage cell maintenance and melanoma metastasis. It is representative of a recently discovered family of proteins that contain a Src Homologous 3 (SH3) subdomain. While SH3 domains are normally found in intracellular proteins and mediate protein-protein interactions via recognition of polyproline helices, MIA is single-domain extracellular protein, and it probably binds to a different class of ligands.

Here we report the assignments, solution structure, and dynamics of human MIA determined by heteronuclear NMR methods. The structures were calculated in a semi-automated manner without manual assignment of NOE crosspeaks, and have a backbone rmsd of 0.38 Å over the ordered regions of the protein. The structure consists of an SH3-like subdomain with N- and C-terminal extensions of approximately 20 amino acids each that together form a novel fold. The rmsd between the solution structure and our recently reported crystal structure is 0.86 Å over the ordered regions of the backbone, and the main differences are localized to the most dynamic regions of the protein. The similarity between the NMR and crystal structures supports the use of automated NOE assignments and ambiguous restraints to accelerate the calculation of NMR structures.

ambiguous restraints automated NOE assignments CD-RAP crystal structure MIA NMR structure SH3 subdomain 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albelda, S.M., Mette, S.A., Elder, D.E., Stewart, R., Damjanovich, L., Herlyn, M. and Buck, C.A. (1990) Cancer Res., 50, 6757–6764.Google Scholar
  2. Archer, S.J., Ikura, M., Torchia, D.A. and Bax, A. (1991) J. Magn. Reson., 95, 636–641.Google Scholar
  3. Bax, A., Clore, G.M. and Gronenborn, A.M. (1990) J. Magn. Reson., 88, 425–431.Google Scholar
  4. Bax, A., Max, D. and Zax, D. (1992) J. Am. Chem. Soc., 114, 6923–6925.Google Scholar
  5. Bax, A., Vuister, G.W., Grzesiek, S., Delaglio, F., Wang, A.C., Tschudin, R. and Zhu, G. (1994) Meth. Enzymol., 239, 79–105.Google Scholar
  6. Blesch, A., Bosserhoff, A.K., Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Buettner, R. and Bogdahn, U. (1994) Cancer Res.,54, 5695–5701.Google Scholar
  7. Bosserhoff, A.K., Golob, M., Buettner, R., Landthaler, M. and Hein, R. (1998) Hautarzt, 49, 762–769.Google Scholar
  8. Bosserhoff, A.K., Kaufmann, M., Kaluza, B., Bartke, I., Zirngibl, H., Hein, R., Stolz, W. and Buettner, R. (1997a) Cancer Res., 57, 3149–3153.Google Scholar
  9. Bosserhoff, A.K., Kondo, S., Moser, M., Dietz, U.H., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Buettner, R. and Sandell, L.J. (1997b) Dev. Dynam., 208, 516–525.Google Scholar
  10. Brunger, A.T. (1992) X-PLOR Manual, Version 3.0, Yale University Press, New Haven, CT.Google Scholar
  11. Chen, H., Hughes, D.D., Chan, T.A., Sedat, J.W. and Agard, D.A. (1996) J. Struct. Biol., 116, 56–60.Google Scholar
  12. Clore, G.M., Kay, L.E., Bax, A. and Gronenborn, A.M. (1991) Biochemistry, 30, 12–18.Google Scholar
  13. Clowes, R.T., Boucher, W., Hardman, C.H., Domaille, P.J. and Laue, E.D. (1993) J. Biomol. NMR, 3, 349–354.Google Scholar
  14. Dietz, U.H. and Sandell, L.J. (1996) J. Biol. Chem., 271, 3311–3316.Google Scholar
  15. Durr, J., Goodman, S., Potocnik, A., von der Mark, H. and von der Mark, K. (1993) Exp. Cell Res., 207, 235–244.Google Scholar
  16. Folmer, R.H., Hilbers, C.W., Konings, R.N. and Nilges, M. (1997) J. Biomol. NMR, 9, 245–258.Google Scholar
  17. Golob, M., Buettner, R. and Bosserhoff, A.K. (2000) J. Invest. Dermatol., 115, 42–47.Google Scholar
  18. Grzesiek, S. and Bax, A. (1992a) J. Am. Chem. Soc., 114, 6291–6293.Google Scholar
  19. Grzesiek, S. and Bax, A. (1992b) J. Magn. Reson.,99, 201–207.Google Scholar
  20. Grzesiek, S., Kuboniwa, H., Hinck, A.P. and Bax, A. (1995) J. Am. Chem. Soc., 117, 5312–5315.Google Scholar
  21. Grzesiek, S., Vuister, G.W. and Bax, A. (1993) J. Biomol. NMR, 3, 487–493.Google Scholar
  22. Guba, M., Bosserhoff, A.K., Steinbauer, M., Abels, C., Anthuber, M., Buettner, R. and Jauch, K.W. (2000) Br. J. Cancer,83, 1216–22.Google Scholar
  23. Kabsch, W. and Sander, C. (1983) Biopolymers, 22, 2577–2637.Google Scholar
  24. Kay, L.E., Clore, G.M., Bax, A. and Gronenborn, A.M. (1990) Science, 249, 411–414.Google Scholar
  25. Kay, L.E., Torchia, D.A. and Bax, A. (1989) Biochemistry, 28, 8972–8979.Google Scholar
  26. Koradi, R., Billeter, M. and Wuthrich, K. (1996) J. Mol. Graph., 14, 29–32.Google Scholar
  27. Kraulis, P.J. (1991) J. Appl. Crystallogr., 24, 946–950.Google Scholar
  28. Kraulis, P.J., Domaille, P.J., Campbell-Burk, S.L., Van Aken, T. and Laue, E.D. (1994) Biochemistry, 33, 3515–3531.Google Scholar
  29. Kuboniwa, H., Grzesiek, S., Delaglio, F. and Bax, A. (1994) J. Biomol. NMR, 4, 871–878.Google Scholar
  30. Larson, S.M. and Davidson, A.R. (2000) Protein Sci., 9, 2170–2180.Google Scholar
  31. Laskowski, R.A., Macarthur, M.W., Moss, D.S. and Thornton, J.M. (1993) J. Appl. Crystallogr., 26, 283–291.Google Scholar
  32. Linge, J.P. and Nilges, M. (1999) J. Biomol. NMR, 13, 51-59.Google Scholar
  33. Linge, J.P., O'Donoghue, S.I., Nilges, M. (2001) Meth. Enzymol., 339, 71–90.Google Scholar
  34. Lougheed, J.C., Holton, J.M., Alber, T., Bazan, J.F. and Handel, T.M. (2001) Proc. Natl. Acad. Sci. USA, 98, 5515–5520.Google Scholar
  35. Luh, F.Y., Archer, S.J., Domaille, P.J., Smith, B.O., Owenm D., Brotherton, D.H., Raine, A.R., Xu, X., Brizuela, L., Brenner, S.L. and Laue, E.D. (1997) Nature, 389, 999–1003.Google Scholar
  36. Musacchio, A., Wilmanns, M. and Saraste, M. (1994) Prog. Biophys. Mol. Biol., 61, 283–297.Google Scholar
  37. Neidhardt, F.C., Bloch, P.L. and Smith, D.F. (1974) J. Bacteriol., 119, 736–747.Google Scholar
  38. Nilges, M., Macias, M.J., O'Donoghue, S.I. and Oschkinat, H. (1997) J. Mol. Biol., 269, 408–422.Google Scholar
  39. Pan, Y. (2000) International Publication Number WO 00/12762, A novel protein related to melanoma-inhibiting protein and uses thereof. U.S. Patent Office.Google Scholar
  40. Robertson, N.G., Heller, S., Lin, J.S., Resendes, B.L., Weremowicz, S., Denis, C.S., Bell, A.M., Hudspeth, A.J. and Morton, C.C. (2000) Genomics, 66, 242–248.Google Scholar
  41. Ruoslahti, E. (1988) Annu. Rev. Biochem., 57, 375–413.Google Scholar
  42. Ruoslahti, E. (1996) Annu. Rev. Cell Dev. Biol., 12, 697–715.Google Scholar
  43. Stoll, R., Renner, C., Zweckstetter, M., Bruggert, M., Ambrosius, D., Palme, S., Engh, R.A., Golob, M., Breibach, I., Buettner, R., Voelter, W., Holak, T.A. and Bosserhoff, A.K. (2001) EMBO J., 20, 340–349.Google Scholar
  44. Talluri, S. and Wagner, G. (1996) J. Magn. Reson. Series, B112, 200–205.Google Scholar
  45. Underwood, P.A., Bennett, F.A., Kirkpatrick, A., Bean, P.A. and Moss, B.A. (1995) Biochem. J., 309, 765–771.Google Scholar
  46. Varner, J.A. and Cheresh, D.A. (1996) Curr. Opin. Cell Biol., 8, 724–730.Google Scholar
  47. Vuister, G.W. and Bax, A. (1992) J. Magn. Reson., 98, 428–435.Google Scholar
  48. Vuister, G.W., Wang, A.C. and Bax, A. (1993) J. Am. Chem. Soc., 115, 5334–5335.Google Scholar
  49. Wishart, D.S., Bigam, C.G., Holm, A., Hodges, R.S. and Sykes, B.D. (1995) J. Biomol. NMR, 5, 67–81.Google Scholar
  50. Yamazaki, T., Forman-Kay, J.D. and Kay, L.E. (1993) J. Am. Chem. Soc., 115, 11054–11055.Google Scholar
  51. Zerbe, O., Szyperski, T., Ottiger, M. and Wüthrich, K. (1996) J. Biomol. NMR, 7, 99–106.Google Scholar
  52. Zuiderweg, E.R.P., McIntosh, L.P., Dahlquist, F.W. and Fesik, S.W. (1990) J. Magn. Reson., 86, 210–216.Google Scholar
  53. Zutter, M.M. and Santoro, S.A. (1990) Am. J. Pathol., 137, 113–120.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Julie C. Lougheed
    • 1
  • Peter J. Domaille
    • 2
  • Tracy M. Handel
    • 1
  1. 1.Department of Molecular and Cell BiologyUniversity of CaliforniaBerkeleyU.S.A
  2. 2.Dupont Pharmaceuticals CompanyWilmingtonU.S.A

Personalised recommendations